Skip to content
March 27, 2024

Equity.Guru

Investment information for the new generation

Search

TBP

Tetra Bio-Pharma (TBP.T) has announced the start of the REBORN1© clinical trial, designed to evaluate the effect of QIXLEEF™, the Company’s inhaled proprietary drug formulation. During this study, QIXLEEF™…
Tetra Bio-Pharma (TBP.T), a leader in cannabinoid-derived drug discovery and development, has announced that is has signed a Definitive Agreement with DanCann Pharma for the exclusive distribution of Reduvo™…
Another day, another Tetra Bio-Pharma (TBP.T) news release. A day after they were granted a Drug Establishment Licence by Health Canada for their REDUVO soft gel capsules, Tetra announced…
Tetra Bio-Pharma (TBP.T), a leader in cannabinoid-derived drug discovery and development, announced today that it has been granted a Health Canada Drug Establishment License (DEL) to distribute REDUVO soft…
It’s time for your Tuesday cannabis rundown. First up: The Green Organic Dutchman Holdings (TGOD.T) signed a letter of intent with the Societe quebecoise du cannabis (SQDC) before its…
Tetra Biopharma (TBP.V) has been busy conducting clinical development programs of two potential products, the first being Quixleef and the second Plenitude. Both involve dealing with uncontrolled pain in…
So Chris Parry had a really good take on the news this week about the TSX suddenly deciding that Drugs Are Bad(™) and in case the great elephant to…